FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000921619> ?p ?o ?g. }

• W2000921619 abstract "Serum carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA) are currently employed in clinical practice as markers for breast cancer, particularly in the follow-up and therapy monitoring. However, the American Society for Clinical Oncology (ASCO) stated in its clinical practice guidelines for the use of tumour markers in breast carcinoma that neither CA 15.3 nor CEA are recommended for routine use in screening, diagnosis and surveillance after primary treatment, or in monitoring response to treatment, because current literature data are insufficient. Cytokeratin fragment 21.1 (CYFRA 21.1) assay detects a serum fragment of cytokeratin 19 (CK19) and is employed in the diagnosis and management of lung cancer, particularly of squamous cell histotype. Breast carcinoma has been demonstrated to express CK19 fragments in the primary and metastatic lesions and CK19 mRNA is detectable in peripheral blood from patients affected by breast cancer. We measured serum markers CYFRA 21.1, CEA and CA 15.3 in the sera from 212 females affected by histologically proven breast carcinoma. Patients comprised 96 individuals with untreated primary disease (54 stage I-II, 18 stage III and 24 stage IV), 30 regional (chest-wall and/or lymph-nodes) relapsing disease and 68 metastatic (haematogenous metastases) relapsing disease. Forty-eight patients previously treated by surgery and without any evidence of disease were enrolled to evaluate the role of serum markers in the monitoring for recurrence of the disease. One hundred healthy age-matched females and 65 patients affected by benign mammary gland disease (including 38 patients with mastopathy and 27 with fibroadenoma) were enrolled as controls. Serum levels of all markers increased from controls to patients affected by breast cancer, from stage I-II to stage IV of the breast cancer and from local to advanced recurrence. The comparison of diagnostic accuracy in the detection of primary and relapsing breast cancer showed no significant differences between markers. Univariate and multivariate survival analysis showed a significant statistically prognostic value for CA 15.3 and CYFRA 21.1 but not for CEA. However, the factors N and M were confirmed to be very strong predictors of the patients' survival. Finally, CEA and CYFRA 21.1 detected less recurrences than CA 15.3." @default.
• W2000921619 created "2016-06-24" @default.
• W2000921619 creator A5021191432 @default.
• W2000921619 creator A5035992664 @default.
• W2000921619 creator A5040547367 @default.
• W2000921619 creator A5057411375 @default.
• W2000921619 creator A5070370906 @default.
• W2000921619 creator A5091623073 @default.
• W2000921619 date "2002-01-10" @default.
• W2000921619 modified "2023-09-27" @default.
• W2000921619 title "Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)" @default.
• W2000921619 cites W1944919483 @default.
• W2000921619 cites W1955382134 @default.
• W2000921619 cites W1968813883 @default.
• W2000921619 cites W1994745839 @default.
• W2000921619 cites W1997084322 @default.
• W2000921619 cites W2016693266 @default.
• W2000921619 cites W2023761151 @default.
• W2000921619 cites W2038397881 @default.
• W2000921619 cites W2052723163 @default.
• W2000921619 cites W2059749728 @default.
• W2000921619 cites W2111736738 @default.
• W2000921619 cites W2159311982 @default.
• W2000921619 cites W2412094279 @default.
• W2000921619 cites W2414396005 @default.
• W2000921619 cites W2418729498 @default.
• W2000921619 cites W36858338 @default.
• W2000921619 cites W4234660912 @default.
• W2000921619 cites W4302569104 @default.
• W2000921619 doi "https://doi.org/10.1515/cclm.2002.047" @default.
• W2000921619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12005221" @default.
• W2000921619 hasPublicationYear "2002" @default.
• W2000921619 type Work @default.
• W2000921619 sameAs 2000921619 @default.
• W2000921619 citedByCount "27" @default.
• W2000921619 countsByYear W20009216192012 @default.
• W2000921619 countsByYear W20009216192013 @default.
• W2000921619 countsByYear W20009216192014 @default.
• W2000921619 countsByYear W20009216192015 @default.
• W2000921619 countsByYear W20009216192016 @default.
• W2000921619 countsByYear W20009216192017 @default.
• W2000921619 countsByYear W20009216192018 @default.
• W2000921619 countsByYear W20009216192020 @default.
• W2000921619 countsByYear W20009216192021 @default.
• W2000921619 countsByYear W20009216192022 @default.
• W2000921619 crossrefType "journal-article" @default.
• W2000921619 hasAuthorship W2000921619A5021191432 @default.
• W2000921619 hasAuthorship W2000921619A5035992664 @default.
• W2000921619 hasAuthorship W2000921619A5040547367 @default.
• W2000921619 hasAuthorship W2000921619A5057411375 @default.
• W2000921619 hasAuthorship W2000921619A5070370906 @default.
• W2000921619 hasAuthorship W2000921619A5091623073 @default.
• W2000921619 hasConcept C111683008 @default.
• W2000921619 hasConcept C118646709 @default.
• W2000921619 hasConcept C121608353 @default.
• W2000921619 hasConcept C126322002 @default.
• W2000921619 hasConcept C142724271 @default.
• W2000921619 hasConcept C143998085 @default.
• W2000921619 hasConcept C146357865 @default.
• W2000921619 hasConcept C151730666 @default.
• W2000921619 hasConcept C204232928 @default.
• W2000921619 hasConcept C2777387746 @default.
• W2000921619 hasConcept C2777546739 @default.
• W2000921619 hasConcept C2779012181 @default.
• W2000921619 hasConcept C2781447364 @default.
• W2000921619 hasConcept C530470458 @default.
• W2000921619 hasConcept C71924100 @default.
• W2000921619 hasConcept C86803240 @default.
• W2000921619 hasConceptScore W2000921619C111683008 @default.
• W2000921619 hasConceptScore W2000921619C118646709 @default.
• W2000921619 hasConceptScore W2000921619C121608353 @default.
• W2000921619 hasConceptScore W2000921619C126322002 @default.
• W2000921619 hasConceptScore W2000921619C142724271 @default.
• W2000921619 hasConceptScore W2000921619C143998085 @default.
• W2000921619 hasConceptScore W2000921619C146357865 @default.
• W2000921619 hasConceptScore W2000921619C151730666 @default.
• W2000921619 hasConceptScore W2000921619C204232928 @default.
• W2000921619 hasConceptScore W2000921619C2777387746 @default.
• W2000921619 hasConceptScore W2000921619C2777546739 @default.
• W2000921619 hasConceptScore W2000921619C2779012181 @default.
• W2000921619 hasConceptScore W2000921619C2781447364 @default.
• W2000921619 hasConceptScore W2000921619C530470458 @default.
• W2000921619 hasConceptScore W2000921619C71924100 @default.
• W2000921619 hasConceptScore W2000921619C86803240 @default.
• W2000921619 hasIssue "3" @default.
• W2000921619 hasLocation W20009216191 @default.
• W2000921619 hasLocation W20009216192 @default.
• W2000921619 hasOpenAccess W2000921619 @default.
• W2000921619 hasPrimaryLocation W20009216191 @default.
• W2000921619 hasRelatedWork W1663546129 @default.
• W2000921619 hasRelatedWork W1863700672 @default.
• W2000921619 hasRelatedWork W2000921619 @default.
• W2000921619 hasRelatedWork W2139425553 @default.
• W2000921619 hasRelatedWork W2352123422 @default.
• W2000921619 hasRelatedWork W2378679291 @default.
• W2000921619 hasRelatedWork W2384739398 @default.
• W2000921619 hasRelatedWork W2409755359 @default.
• W2000921619 hasRelatedWork W2513966554 @default.
• W2000921619 hasRelatedWork W3029946366 @default.
• W2000921619 hasVolume "40" @default.

• next